MetaVia shares surge 195.77% after hours as 1-for-11 reverse stock split announced to comply with Nasdaq listing requirements.

MetaVia Inc. surged 195.77% in after-hours trading following the implementation of a 1-for-11 reverse stock split, announced earlier in the day to comply with Nasdaq’s minimum bid price requirements. The split reduces outstanding shares from 25.4 million to 2.3 million, enhancing the stock’s per-share value and market stability. The move, approved by shareholders in June, aims to avoid delisting and aligns with the company’s focus on developing cardiometabolic therapies. Fractional shares were rounded down, with cash compensation provided, ensuring shareholder equity remains unaffected. The significant post-announcement rally reflects investor optimism about the company’s strategic compliance efforts and renewed focus on long-term growth in its core therapeutic areas.